BeiGene Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.

BeiGene Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.

BenzingaMay 8 10:31 ET

BeiGene GAAP EPADS of -$2.41 Beats by $0.48, Revenue of $751.65M Beats by $76.42M

Seeking AlphaMay 8 06:16 ET

BeiGene Q1 2024 GAAP EPADS $(2.41) Beats $(2.89) Estimate, Sales $751.652M Beat $676.451M Estimate

BeiGene (NASDAQ:BGNE) reported quarterly losses of $(2.41) per share which beat the analyst consensus estimate of $(2.89) by 16.61 percent. This is a 27.84 percent increase over losses of $(3.34) per

BenzingaMay 8 06:10 ET

信達生物：2023年報

Futu NewsApr 29 10:36 ET · Announcements

康方生物：2023 年報

Futu NewsApr 29 10:30 ET · Announcements

翰森製藥：2023年報

Futu NewsApr 29 09:43 ET · Announcements